Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Jan
6
2015
Paramount Home Entertainment Inc., Twentieth Century Fox Home Entertainment LLC, and Universal Studios Home Entertainment LLC v. Nissim Corporation, IPR2014-00961: Denying Institution IPR2014-00961 Faegre Drinker
Jan
5
2015
USPTO Publishes New Guidelines for Patent-Eligible Subject Matter: Naturally Derived Subject Matter Faegre Drinker
Jan
5
2015
Robinson v. JoeyBra LLC - Design Patent Case Digest Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jan
5
2015
Patenting: Claim Scope and the Actor(s) in a Claim Womble Bond Dickinson (US) LLP
Jan
5
2015
Guardian Accused Of Wrongfully Treating Humidifier Goo re: Patent Litigation Womble Bond Dickinson (US) LLP
Jan
5
2015
Be Mindful of Your Claims in Divisional Applications and Patents in South Africa Michael Best & Friedrich LLP
Jan
4
2015
Post-Alice—Claims Directed to an Abstract Idea Must Have Meaningful Limitations McDermott Will & Emery
Jan
4
2015
Patent Owner without Control of Licensee Has No Standing to Sue McDermott Will & Emery
Jan
4
2015
UC Ventures: How One Very Large Public University System is Setting an Example. Or is it? Greenberg Traurig, LLP
Jan
4
2015
Obviousness Must Be Supported by Analysis and Factual Findings McDermott Will & Emery
Jan
4
2015
Provisional Patents as a Strategy for Tech Start-Ups Greenberg Traurig, LLP
Jan
4
2015
Pro Se Not Welcome at PTAB McDermott Will & Emery
Jan
4
2015
Identifying the Real Party in Interest in Intellectual Property McDermott Will & Emery
Jan
4
2015
“Nonce” Words and Means-Plus-Function Analysis McDermott Will & Emery
Jan
3
2015
Winning The Battle But Losing The War? - New Considerations For File Wrapper Estoppel Hunton Andrews Kurth
Jan
3
2015
Prior Art Reference Does Not “Teach Away” if It Fails to Criticize, Disclaim or Discourage the Claimed Technique McDermott Will & Emery
Jan
3
2015
Beyond the Neon: Emerging Tech Opportunities in Las Vegas Greenberg Traurig, LLP
Jan
3
2015
The Advocate General of the EU Clarifies Position on Enforcement of SEPs (Standard-essential Patents) McDermott Will & Emery
Jan
3
2015
Post Exclusivity Issues For Biologics Hunton Andrews Kurth
Jan
3
2015
PTAB Issues Rare Dissent in Non-Institution Decision McDermott Will & Emery
Jan
3
2015
Federal Circuit Court of Appeals Delivers Another Decision on Patentability of Myriad Patents Mintz
Jan
3
2015
Stays of Litigation Warranted Even When the CBM Review Does Not Address All Asserted Claims or All Invalidity Defenses McDermott Will & Emery
Jan
3
2015
BioDelivery Sciences International, Inc. v. RB Pharmaceuticals Limited: IPR2014-00998 Denying Institution and Dismissing Motion for Joinder IPR2014-00998 Faegre Drinker
Jan
3
2015
A First Look at New York City’s Next Generation of Entrepreneurs Greenberg Traurig, LLP
Jan
3
2015
Patent Owner Must Distinguish Universe of All Known Prior Art to Substitute a New Claim McDermott Will & Emery
Jan
2
2015
Deposition of Declarants Is Limited after Routine Discovery McDermott Will & Emery
Jan
2
2015
Navigating Degrees of Separation: Impermissible Incorporation by Reference McDermott Will & Emery
Jan
2
2015
Serial Objections to Evidence Are Not Required if Supplemental Evidence Is Filed and Served McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins